Skip to content
Disclosery

EXANE DERIVATIVES: PLUG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PLUG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 57 PLUG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 57 shares
    Change vs previous 13F -8,768 shares

    <0.01% of the 13F portfolio, value $944.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,825 shares
    Change vs previous 13F +51 shares

    0.07% of the 13F portfolio, value $252,488.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 8,774 shares
    Change vs previous 13F -2,482 shares

    0.06% of the 13F portfolio, value $247,701.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 11,256 shares
    Change vs previous 13F -71 shares

    0.07% of the 13F portfolio, value $287,492.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 11,327 shares
    Change vs previous 13F -16,692 shares

    0.07% of the 13F portfolio, value $315,125.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 28,019 shares
    Change vs previous 13F +11,495 shares

    0.3% of the 13F portfolio, value $1,004,256.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 16,524 shares
    Change vs previous 13F not available

    0.17% of the 13F portfolio, value $560,358.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).